ArticleScientific reports2017

PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.

Wei Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.